FindMyRecallSubscribe
Class I: serious health riskTerminated

Fresenius Kabi Midazolam Injection Recall

Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL (1 mg / mL), 24 X 2mL Prefille…

Fresenius Kabi USA, LLC · Wilson, NC

Risk level
Class I
Reported by FDA
Jan 10, 2018
Recall ID
D-0152-2018
Check your lot numberHow we source this data

Summary

Fresenius Kabi recalled Midazolam Injection starting Oct 27, 2017. The FDA classified it as Class I (serious health risk) and published enforcement report D-0152-2018 on Jan 10, 2018. Reason: Labeling: Label MIX-UP. Blister Packages, Labeled as Midazolam injection, USP, 2 mg / 2 ml, Containing Syringes of Ondansetron Injection, USP, 4 mg / 2 mL. Status: Terminated.

Why it was recalled

Labeling: Label MIX-UP. Blister Packages, Labeled as Midazolam injection, USP, 2 mg / 2 ml, Containing Syringes of Ondansetron Injection, USP, 4 mg / 2 mL

Product description

Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL (1 mg / mL), 24 X 2mL Prefilled single-use syringes per carton, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 76045-001-20

Lot numbers, UPCs & expiration codes

Lot: 6400048

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0152-2018
Classification
Class I
Status
Terminated
Recall initiated
Oct 27, 2017
FDA report date
Jan 10, 2018
Quantity
203136 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Fresenius Kabi USA, LLC

Original FDA data

Every field from FDA enforcement report D-0152-2018, exactly as published.

Show all FDA fields
City
Wilson
State
NC
Status
Terminated
Country
United States
Event ID
78396
Address
5200 Corporate Pkwy
Code information
Lot: 6400048
Postal code
27893-9412
Report date
Jan 10, 2018
Product type
Drugs
Recall number
D-0152-2018
Classification
Class I
Recalling firm
Fresenius Kabi USA, LLC
Product quantity
203136 syringes
Termination date
Oct 5, 2020
Reason for recall
Labeling: Label MIX-UP. Blister Packages, Labeled as Midazolam injection, USP, 2 mg / 2 ml, Containing Syringes of Ondansetron Injection, USP, 4 mg / 2 mL
Voluntary / mandated
Voluntary: Firm initiated
Product description
Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL (1 mg / mL), 24 X 2mL Prefilled single-use syringes per carton, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 76045-001-20
Distribution pattern
Nationwide in the USA
Recall initiation date
Oct 27, 2017
Initial firm notification
Letter
Center classification date
Jan 4, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0152-2018, published Jan 10, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls